aligntech.com - ALGN Company Value to Revenue Ratio

Public company logo of Align Technology (ALGN)

Geopolitical risks and currency fluctuations are complicating logistics for Align Technology, Inc. (ALGN), as clearly demonstrated by the EV-to-sales ratio. The 2466.43 mark reflects the latest data on the business valuation. However, leadership in 3D-printed aligners is transforming dentistry, while high loyalty among R&D engineers and IT specialists guarantees the company stable development without labor shortages.

ALGN Align Technology, Inc.: EV/Sales Multiple in the range 11/23/2025 - 11/20/2026

ALGN (Align Technology Inc): analytical breakdowns and indicator data

Fundamental valuation:Align Technology, Inc. ALGN
Mass-produced product of Invisalign

For an investor in Align Technology, Inc. (ALGN), this indicator serves as a tool for assessing the market value of the business relative to its operating revenues. By analyzing the company's enterprise value to revenue—which combines market capitalization and net debt—one can determine the asset's degree of overvaluation without the influence of credit leverage. The global diversification of Invisalign and iTero sales stabilizes this ratio, confirming the resilience of the company's fundamental metrics against local economic shocks.

Competitor analysis for Align Technology, Inc.

BSX (Boston Scientific) - Company Value to Revenue Ratio|EW: EV/Sales Multiple|RMD - Total Company Value-to-Revenue Ratio|PODD (Insulet Inc.) - EV/Sales Multiple|Company Value to Revenue Zimmer Biomet Corp (ZBH)|EV/Sales Multiple COO|Company Value to Revenue Globus Medical, Inc. GMED|EV/Sales Multiple TMDX (transmedics.com)|EV/Sales Multiple Alphatec Holdings ATEC|AORT - Enterprise Value-to-Revenue Ratio|ENOV: Enterprise Value-to-Revenue Ratio|IART (Integra LifeSciences) - Company Value to Revenue|Establishment Labs - Business Value to Revenue|BBNX (iLet Bionic Pancreas) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple IRADIMED Corp IRMD|Enterprise Value-to-Revenue Ratio Embecta Corp (EMBC)|Tandem Diabetes Care (TNDM) - Enterprise Value-to-Sales Ratio|Axogen Surgical - Company Value to Revenue|EV/Sales Multiple SI-BONE, Inc. SIBN|Orthofix Medical - EV/Sales Multiple|Enterprise Value to Sales Volume BVS|OrthoPediatrics (KIDS) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume TMCI (Treace Corp)|Enterprise Value-to-Revenue Ratio blade.com|Company Value to Revenue Carlsmed Inc (CARL)|EV/Sales Multiple RXST|CLPT - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Stereotaxis, Inc. STXS|STIM: Company Value to Revenue Ratio|SGHT: Company Value to Revenue|Orchestra BioMed Inc. - Enterprise Value-to-Revenue Coefficient|ANIK: EV/Sales Multiple|NSPR - Total Company Value-to-Revenue Ratio|ZJYL (Jin Medical) - EV/Sales Multiple|Vivani Medical (VANI) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple XTNT|EV/Sales Multiple n1mtc.com (NMTC)|Modular Medical Inc - Company Value to Revenue|Myomo, Inc (MYO) - Enterprise Value-to-Revenue Multiple|COCH: Company Value to Revenue|Total Company Value-to-Revenue Ratio Vivos Therapeutics VVOS|enVVeno Medical Corp. (NVNO) - Enterprise Value-to-Revenue Ratio|Sintx Technologies - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Tenon Medical Inc.|LFWD: Business Value to Revenue|EV/Sales Multiple AMIX|Enterprise Value-to-Revenue Coefficient IVF|Enterprise Value-to-Revenue Ratio Bone Biologics BBLG|Total Company Value-to-Revenue Ratio axonics.com (AXNX)|BIOL - Enterprise Value-to-Revenue Ratio|Dynatronics (DYNT) - Company Value to Revenue|Paragon 28, Inc. (FNA) - Enterprise Value-to-Revenue Ratio|INVO - Total Company Value-to-Revenue Ratio